QHSLab Inc. (USAQ): $USAQ “The $1.6 million acquisition of t...

Reply Private New

Replies (2) Next 10 Prev Next

Send PM Follow Ignore

Followers	0
Posts	7710
Boards Moderated	0
Alias Born	05/05/2020

lucky__stock

Re: None

Tuesday, 04/12/2022 11:59:53 AM

Tuesday, April 12, 2022 11:59:53 AM

$USAQ “The $1.6 million acquisition of the AllergiEnd® assets in June 2021 has created a robust strategic platform to build upon in 2022 and beyond. The revenue generated from AllergiEnd® product sales was $329,989 in the fourth quarter of 2021 compared to $124,532 for the same period in 2020 and $1,414,421 for the year 2021 compared to $124,532 for 2020. In addition, our physician practice clients generated approximately $5,000,000 in revenues utilizing our products during 2021. This is a huge benefit to our physician clients especially in this current climate of decreasing reimbursements for primary care physicians,” said USAQ CEO Troy Grogan.

Keep Last Read

Replies (2) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent USAQ News

Form 8-K - Current report • Edgar (US Regulatory) • 09/17/2024 01:00:09 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2024 01:25:54 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2024 12:00:41 PM
Form 8-K - Current report • Edgar (US Regulatory) • 06/07/2024 08:57:31 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2024 01:00:32 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2024 12:00:46 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/30/2024 01:30:13 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 09:00:50 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/25/2023 01:00:30 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/18/2023 12:00:27 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/06/2023 02:33:13 PM